Manikay Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Manikay Partners’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,123,000	Closed	-$27.1M	–	36
2017 Q2	$27.1M	Buy	+1,123,000	New	+$28.6M	1.72%	18

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manikay Partners's SBRA Position: Q3 2017 in Review

Manikay Partners sold out of Sabra Healthcare REIT (SBRA) in Q3 2017, closing a stake of 1,123,000 shares — an estimated $27.1M sold.

Manikay Partners first reported a position in SBRA in Q2 2017 and held it in 1 quarter. The position peaked at $27.1M in Q2 2017. 337 funds tracked by Wall St. Rank hold SBRA as of Q3 2017.

Manikay Partners reported no remaining Sabra Healthcare REIT position as of Q3 2017 after selling out during the quarter.
Manikay Partners sold 1,123,000 Sabra Healthcare REIT shares in Q3 2017, an estimated $27.1M.
Manikay Partners first reported a position in Sabra Healthcare REIT in Q2 2017 and held it in 1 quarter.
Manikay Partners's Sabra Healthcare REIT position peaked at $27.1M in Q2 2017.
337 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2017.

Based on Manikay Partners's 13F filing for Q3 2017, filed 13 Nov 2017.